Ferguson Wellman Capital Management, Inc Amgen Inc Transaction History

Ferguson Wellman Capital Management, Inc

$4.99 Billion
Q3 2024

A detailed history of Ferguson Wellman Capital Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 19,917 shares of AMGN stock, worth $5.25 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

19,917

Previous 19,677 1.22%

Holding current value

$5.25 Million

Previous $6.34 Million 1.21%

% of portfolio

0.13%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $74,251 - $80,971	240 Added 1.22%	19,917 $6.42 Million
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $125,917 - $137,313	-407 Reduced 2.03%	19,677 $6.34 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $333,955 - $405,843	-1,271 Reduced 5.95%	20,084 $6.28 Million
Q1 2024 Apr 09, 2024	SELL	$268.87 - $324.56 $324,257 - $391,419	-1,206 Reduced 5.35%	21,355 $6.07 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $190,496 - $214,902	745 Added 3.41%	22,561 $6.5 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $557,994 - $692,765	-2,552 Reduced 10.47%	21,816 $5.86 Million
Q2 2023 Jul 11, 2023	SELL	$214.27 - $253.37 $154,702 - $182,933	-722 Reduced 2.88%	24,368 $5.41 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $161,214 - $196,492	-714 Reduced 2.77%	25,090 $6.07 Million
Q4 2022 Jan 13, 2023	BUY	$229.03 - $291.01 $1.51 Million - $1.92 Million	6,613 Added 34.46%	25,804 $6.78 Million
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $197,300 - $222,518	-879 Reduced 4.38%	19,191 $4.33 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $145,347 - $161,746	-630 Reduced 3.04%	20,070 $4.88 Million
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $673,378 - $744,932	-3,071 Reduced 12.92%	20,700 $5.01 Million
Q4 2021 Jan 10, 2022	SELL	$198.88 - $227.6 $1.09 Million - $1.25 Million	-5,479 Reduced 18.73%	23,771 $5.35 Million
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $1.9 Million - $2.22 Million	-8,935 Reduced 23.4%	29,250 $6.22 Million
Q2 2021 Jul 12, 2021	SELL	$233.58 - $259.14 $18.5 Million - $20.5 Million	-79,053 Reduced 67.43%	38,185 $9.31 Million
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $14.5 Million - $17 Million	-65,554 Reduced 35.86%	117,238 $29.2 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $112,301 - $133,730	-519 Reduced 0.28%	182,792 $42 Million
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $99,256 - $110,381	423 Added 0.23%	183,311 $46.6 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $5.66 Million - $6.94 Million	-28,599 Reduced 13.52%	182,888 $43.1 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $150,348 - $199,402	-825 Reduced 0.39%	211,487 $42.9 Million
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $23,272 - $29,913	-123 Reduced 0.06%	212,312 $51.2 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $370,331 - $443,734	2,127 Added 1.01%	212,435 $41.1 Million
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $15,669 - $18,368	-94 Reduced 0.04%	210,308 $38.8 Million
Q1 2019 Apr 11, 2019	BUY	$180.87 - $203.88 $403,159 - $454,448	2,229 Added 1.07%	210,402 $40 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $223,535 - $260,937	1,253 Added 0.61%	208,173 $40.5 Million
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $180,101 - $203,041	-972 Reduced 0.47%	206,920 $42.9 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $11.1 Million - $12.5 Million	-67,048 Reduced 24.39%	207,892 $38.4 Million
Q1 2018 Apr 09, 2018	SELL	$169.43 - $198.0 $101,488 - $118,602	-599 Reduced 0.22%	274,940 $46.9 Million
Q4 2017 Jan 24, 2018	BUY	$168.79 - $188.59 $298,589 - $333,615	1,769 Added 0.65%	275,539 $47.9 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $45.8 Million - $52.3 Million	273,770	273,770 $51 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.

Account

Ferguson Wellman Capital Management, Inc Amgen Inc Transaction History